New T-cell based Treatment for Type 1 Diabetes Shows Early Promise

“This is a very novel approach to treatment because it deals with the route cause for type 1 diabetes — which is destruction of the insulin-producing cells of the pancreas by one’s own immune system,” said Dr. Deena Adimoolam, assistant professor of medicine, endocrinology, diabetes and bone disease at the Icahn School of Medicine at Mount Sinai in New York City.

Read more

Posted in Medical Research